Search - tctmd.com

Displaying 61 - 80 of 469

Sort: Relevancy | Date

News Conference News ACC 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Shelley Wood

March 10, 2023

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

News Daily News

Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes

Todd Neale

February 07, 2023

News Conference News STS 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

Yael L. Maxwell

February 02, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

New-Onset AF Not Uncommon After Mitral TEER

Todd Neale

September 13, 2022

News Daily News

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

L.A. McKeown

September 09, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

Advertisement

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

FDA Approves Pascal TEER Device for Degenerative MR

New-Onset AF Not Uncommon After Mitral TEER

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content